These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1449 related items for PubMed ID: 19152393
1. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ. J Med Virol; 2009 Mar; 81(3):406-12. PubMed ID: 19152393 [Abstract] [Full Text] [Related]
2. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918 [Abstract] [Full Text] [Related]
3. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397 [Abstract] [Full Text] [Related]
4. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India. Gupta S, Singh S. BMC Infect Dis; 2010 Mar 07; 10():53. PubMed ID: 20205948 [Abstract] [Full Text] [Related]
5. [Investigation of occult hepatitis B in HIV infected patients]. Altınbaş A, Ergünay K, Calık Başaran N, Alp A, Turgut D, Hasçelik G, Uzun Ö, Unal S. Mikrobiyol Bul; 2011 Apr 07; 45(2):353-8. PubMed ID: 21644079 [Abstract] [Full Text] [Related]
6. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study. Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe P, Leroy V, Dabis F, Rouzioux C, ANRS 1236 DITRAME-B&C Study Group. J Med Virol; 2004 Sep 07; 74(1):34-40. PubMed ID: 15258966 [Abstract] [Full Text] [Related]
7. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients. Selabe SG, Lukhwareni A, Song E, Leeuw YG, Burnett RJ, Mphahlele MJ. J Med Virol; 2007 Nov 07; 79(11):1650-4. PubMed ID: 17854040 [Abstract] [Full Text] [Related]
8. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A. Trop Gastroenterol; 2007 Nov 07; 28(1):19-23. PubMed ID: 17896605 [Abstract] [Full Text] [Related]
9. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM. J Med Virol; 2007 Oct 07; 79(10):1464-71. PubMed ID: 17705185 [Abstract] [Full Text] [Related]
11. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group. Transfusion; 2004 Sep 07; 44(9):1332-9. PubMed ID: 15318857 [Abstract] [Full Text] [Related]
12. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B]. Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC. Mikrobiyol Bul; 2007 Apr 07; 41(2):227-33. PubMed ID: 17682709 [Abstract] [Full Text] [Related]
14. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy. Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E. HIV Med; 2010 Jan 07; 11(1):85-9. PubMed ID: 19659944 [Abstract] [Full Text] [Related]
15. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment]. Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ. Zhonghua Gan Zang Bing Za Zhi; 2013 Mar 07; 21(3):189-91. PubMed ID: 23967739 [Abstract] [Full Text] [Related]
16. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S, Nakashima Y, Kojiro M, Tabor E. J Viral Hepat; 2005 May 07; 12(3):325-9. PubMed ID: 15850475 [Abstract] [Full Text] [Related]
17. Occult hepatitis B virus infection: implications in transfusion. Allain JP. Vox Sang; 2004 Feb 07; 86(2):83-91. PubMed ID: 15023176 [Abstract] [Full Text] [Related]
18. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China. Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR. Transfus Apher Sci; 2009 Aug 07; 41(1):3-7. PubMed ID: 19487161 [Abstract] [Full Text] [Related]
19. Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Song EY, Yun YM, Park MH, Seo DH. Intervirology; 2009 Aug 07; 52(2):57-62. PubMed ID: 19401629 [Abstract] [Full Text] [Related]
20. High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants. Launay O, Masurel J, Servant-Delmas A, Basse-Guérineau AL, Méritet JF, Laperche S, Sogni P, Rosenberg AR. J Viral Hepat; 2011 Oct 07; 18(10):721-9. PubMed ID: 21914087 [Abstract] [Full Text] [Related] Page: [Next] [New Search]